A citation-based method for searching scientific literature

David Soong, Jeran Stratford, Herve Avet-Loiseau, Nizar Bahlis, Faith Davies, Angela Dispenzieri, A Kate Sasser, Jordan M Schecter, Ming Qi, Chad Brown, Wendell Jones, Jonathan J Keats, Daniel Auclair, Christopher Chiu, Jason Powers, Michael Schaffer. BMC Bioinformatics 2020
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


DELLY: structural variant discovery by integrated paired-end and split-read analysis.
Tobias Rausch, Thomas Zichner, Andreas Schlattl, Adrian M Stütz, Vladimir Benes, Jan O Korbel. Bioinformatics 2012
803
100

Genomic landscape and chronological reconstruction of driver events in multiple myeloma.
Francesco Maura, Niccoló Bolli, Nicos Angelopoulos, Kevin J Dawson, Daniel Leongamornlert, Inigo Martincorena, Thomas J Mitchell, Anthony Fullam, Santiago Gonzalez, Raphael Szalat,[...]. Nat Commun 2019
70
50

Punctuated evolution of prostate cancer genomes.
Sylvan C Baca, Davide Prandi, Michael S Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y MacDonald, Mahmoud Ghandi,[...]. Cell 2013
713
50

Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation.
Maura Costello, Trevor J Pugh, Timothy J Fennell, Chip Stewart, Lee Lichtenstein, James C Meldrim, Jennifer L Fostel, Dennis C Friedrich, Danielle Perrin, Danielle Dionne,[...]. Nucleic Acids Res 2013
245
50

Mutational processes contributing to the development of multiple myeloma.
Phuc H Hoang, Alex J Cornish, Sara E Dobbins, Martin Kaiser, Richard S Houlston. Blood Cancer J 2019
12
50


Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters.
Biola M Javierre, Oliver S Burren, Steven P Wilder, Roman Kreuzhuber, Steven M Hill, Sven Sewitz, Jonathan Cairns, Steven W Wingett, Csilla Várnai, Michiel J Thiecke,[...]. Cell 2016
382
50

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
50

Identifying cis Elements for Spatiotemporal Control of Mammalian DNA Replication.
Jiao Sima, Abhijit Chakraborty, Vishnu Dileep, Marco Michalski, Kyle N Klein, Nicolas P Holcomb, Jesse L Turner, Michelle T Paulsen, Juan Carlos Rivera-Mulia, Claudia Trevilla-Garcia,[...]. Cell 2019
57
50

Deciphering the chronology of copy number alterations in Multiple Myeloma.
Anil Aktas Samur, Stephane Minvielle, Masood Shammas, Mariateresa Fulciniti, Florence Magrangeas, Paul G Richardson, Philippe Moreau, Michel Attal, Kenneth C Anderson, Giovanni Parmigiani,[...]. Blood Cancer J 2019
21
50

Genomic complexity of multiple myeloma and its clinical implications.
Salomon Manier, Karma Z Salem, Jihye Park, Dan A Landau, Gad Getz, Irene M Ghobrial. Nat Rev Clin Oncol 2017
202
50

Clonal competition with alternating dominance in multiple myeloma.
Jonathan J Keats, Marta Chesi, Jan B Egan, Victoria M Garbitt, Stephen E Palmer, Esteban Braggio, Scott Van Wier, Patrick R Blackburn, Angela S Baker, Angela Dispenzieri,[...]. Blood 2012
412
50

CHiCAGO: robust detection of DNA looping interactions in Capture Hi-C data.
Jonathan Cairns, Paula Freire-Pritchett, Steven W Wingett, Csilla Várnai, Andrew Dimond, Vincent Plagnol, Daniel Zerbino, Stefan Schoenfelder, Biola-Maria Javierre, Cameron Osborne,[...]. Genome Biol 2016
158
50


Multiple Cereblon genetic changes associate with acquired resistance to Lenalidomide or Pomalidomide in Multiple Myeloma.
Sarah Gooding, Naser Ansari-Pour, Fadi Towfic, Maria Ortiz Estevez, Philip P Chamberlain, Kao-Tai Tsai, Erin Flynt, Marissa Hirst, Dan Rozelle, Paula Dhiman,[...]. Blood 2020
11
50

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Jens G Lohr, Petar Stojanov, Scott L Carter, Peter Cruz-Gordillo, Michael S Lawrence, Daniel Auclair, Carrie Sougnez, Birgit Knoechel, Joshua Gould, Gordon Saksena,[...]. Cancer Cell 2014
580
50

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
H Kaufmann, J Ackermann, C Baldia, T Nösslinger, R Wieser, S Seidl, V Sagaster, H Gisslinger, U Jäger, M Pfeilstöcker,[...]. Leukemia 2004
53
50

Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
S Venkatesan, R Rosenthal, N Kanu, N McGranahan, J Bartek, S A Quezada, J Hare, R S Harris, C Swanton. Ann Oncol 2018
52
50

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.
V Shah, A L Sherborne, B A Walker, D C Johnson, E M Boyle, S Ellis, D B Begum, P Z Proszek, J R Jones, C Pawlyn,[...]. Leukemia 2018
81
50

Multiple Myeloma: Available Therapies and Causes of Drug Resistance.
Vanessa Pinto, Rui Bergantim, Hugo R Caires, Hugo Seca, José E Guimarães, M Helena Vasconcelos. Cancers (Basel) 2020
34
50

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
50


Subclonal reconstruction of tumors by using machine learning and population genetics.
Giulio Caravagna, Timon Heide, Marc J Williams, Luis Zapata, Daniel Nichol, Ketevan Chkhaidze, William Cross, George D Cresswell, Benjamin Werner, Ahmet Acar,[...]. Nat Genet 2020
12
50

ReplicationDomain: a visualization tool and comparative database for genome-wide replication timing data.
Nodin Weddington, Alexander Stuy, Ichiro Hiratani, Tyrone Ryba, Tomoki Yokochi, David M Gilbert. BMC Bioinformatics 2008
60
50


Universal Patterns of Selection in Cancer and Somatic Tissues.
Iñigo Martincorena, Keiran M Raine, Moritz Gerstung, Kevin J Dawson, Kerstin Haase, Peter Van Loo, Helen Davies, Michael R Stratton, Peter J Campbell. Cell 2017
379
50

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.
Eric Letouzé, Jayendra Shinde, Victor Renault, Gabrielle Couchy, Jean-Frédéric Blanc, Emmanuel Tubacher, Quentin Bayard, Delphine Bacq, Vincent Meyer, Jérémy Semhoun,[...]. Nat Commun 2017
99
50

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Niels Weinhold, Cody Ashby, Leo Rasche, Shweta S Chavan, Caleb Stein, Owen W Stephens, Ruslana Tytarenko, Michael A Bauer, Tobias Meissner, Shayu Deshpande,[...]. Blood 2016
100
50

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.
K Martin Kortüm, Elias K Mai, Nur H Hanafiah, Chang-Xi Shi, Yuan-Xiao Zhu, Laura Bruins, Santiago Barrio, Patrick Jedlowski, Maximilian Merz, Jing Xu,[...]. Blood 2016
101
50

Identification of neutral tumor evolution across cancer types.
Marc J Williams, Benjamin Werner, Chris P Barnes, Trevor A Graham, Andrea Sottoriva. Nat Genet 2016
273
50


Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma.
Sarah Gooding, Naser Ansari-Pour, Fadi Towfic, María Ortiz Estévez, Philip P Chamberlain, Kao-Tai Tsai, Erin Flynt, Marissa Hirst, Dan Rozelle, Paula Dhiman,[...]. Blood 2021
9
50

Recurrent and functional regulatory mutations in breast cancer.
Esther Rheinbay, Prasanna Parasuraman, Jonna Grimsby, Grace Tiao, Jesse M Engreitz, Jaegil Kim, Michael S Lawrence, Amaro Taylor-Weiner, Sergio Rodriguez-Cuevas, Mara Rosenberg,[...]. Nature 2017
148
50

LUMPY: a probabilistic framework for structural variant discovery.
Ryan M Layer, Colby Chiang, Aaron R Quinlan, Ira M Hall. Genome Biol 2014
535
50

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.
Brian A Walker, Christopher P Wardell, Lorenzo Melchor, Sanna Hulkki, Nicola E Potter, David C Johnson, Kerry Fenwick, Iwanka Kozarewa, David Gonzalez, Christopher J Lord,[...]. Blood 2012
183
50

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Niccolo Bolli, Hervé Avet-Loiseau, David C Wedge, Peter Van Loo, Ludmil B Alexandrov, Inigo Martincorena, Kevin J Dawson, Francesco Iorio, Serena Nik-Zainal, Graham R Bignell,[...]. Nat Commun 2014
501
50

The life history of 21 breast cancers.
Serena Nik-Zainal, Peter Van Loo, David C Wedge, Ludmil B Alexandrov, Christopher D Greenman, King Wai Lau, Keiran Raine, David Jones, John Marshall, Manasa Ramakrishna,[...]. Cell 2012
809
50

Recurrent somatic mutations in regulatory regions of human cancer genomes.
Collin Melton, Jason A Reuter, Damek V Spacek, Michael Snyder. Nat Genet 2015
158
50

Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia.
Tim H Brummendorf, Inci Ersoz, Ulrike Hartmann, Stefan Balabanov, Holger Wolke, Peter Paschka, Tanja Lahaye, Birgit Berner, Kerol Bartolovic, Sebastian Kreil,[...]. Ann N Y Acad Sci 2003
23
50

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.
A Hochhaus, S Kreil, A S Corbin, P La Rosée, M C Müller, T Lahaye, B Hanfstein, C Schoch, N C P Cross, U Berger,[...]. Leukemia 2002
671
50

A practical guide for mutational signature analysis in hematological malignancies.
Francesco Maura, Andrea Degasperi, Ferran Nadeu, Daniel Leongamornlert, Helen Davies, Luiza Moore, Romina Royo, Bachisio Ziccheddu, Xose S Puente, Herve Avet-Loiseau,[...]. Nat Commun 2019
50
50

Reactive oxygen species in cancer.
Geou-Yarh Liou, Peter Storz. Free Radic Res 2010
50

HiCUP: pipeline for mapping and processing Hi-C data.
Steven Wingett, Philip Ewels, Mayra Furlan-Magaril, Takashi Nagano, Stefan Schoenfelder, Peter Fraser, Simon Andrews. F1000Res 2015
176
50

Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine.
Kamil A Lipinski, Louise J Barber, Matthew N Davies, Matthew Ashenden, Andrea Sottoriva, Marco Gerlinger. Trends Cancer 2016
119
50

Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution.
Thomas O McDonald, Shaon Chakrabarti, Franziska Michor. Nat Genet 2018
11
50

Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.
F Favero, T Joshi, A M Marquard, N J Birkbak, M Krzystanek, Q Li, Z Szallasi, A C Eklund. Ann Oncol 2015
220
50

Telomerase and drug resistance in cancer.
Natalia Lipinska, Aleksandra Romaniuk, Anna Paszel-Jaworska, Ewa Toton, Przemyslaw Kopczynski, Blazej Rubis. Cell Mol Life Sci 2017
31
50

Neutral tumor evolution in myeloma is associated with poor prognosis.
David C Johnson, Oleg Lenive, Jonathan Mitchell, Graham Jackson, Roger Owen, Mark Drayson, Gordon Cook, John R Jones, Charlotte Pawlyn, Faith E Davies,[...]. Blood 2017
13
50

Initial genome sequencing and analysis of multiple myeloma.
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, Kristian Cibulskis, Carrie Sougnez, Anna C Schinzel, Christina L Harview, Jean-Philippe Brunet, Gregory J Ahmann, Mazhar Adli,[...]. Nature 2011
992
50

Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications.
Xiaoyu Chen, Ole Schulz-Trieglaff, Richard Shaw, Bret Barnes, Felix Schlesinger, Morten Källberg, Anthony J Cox, Semyon Kruglyak, Christopher T Saunders. Bioinformatics 2016
462
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.